Lander Egaña-Gorroño
Impact in
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Advanced Glycation End Products research 4
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Diabetes Management and Research 1
- Co-authors
- Ann Marie Schmidt (5 shared papers)Alexander Shekhtman (4 shared papers)Ravichandran Ramasamy (4 shared papers)Raquel López‐Díez (4 shared papers)Sergey Reverdatto (2 shared papers)Paul F. Gugger (2 shared papers)Gautham Yepuri (1 shared paper)Mireia Arnedo (8 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Lipid Research (1 paper)AIDS (1 paper)Frontiers in Cardiovascular Medicine (1 paper)Journal of Immunological Methods (1 paper)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Lander Egaña-Gorroño
17 papers receiving 477 citations
Peers
Comparison fields: 5 of 78
- Clinical Biochemistry 147
- Virology 50
- Emergency Medicine 45
- Endocrinology, Diabetes and Metabolism 75
- Cancer Research 56
Countries citing papers authored by Lander Egaña-Gorroño
This map shows the geographic impact of Lander Egaña-Gorroño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lander Egaña-Gorroño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lander Egaña-Gorroño more than expected).
Fields of papers citing papers by Lander Egaña-Gorroño
This network shows the impact of papers produced by Lander Egaña-Gorroño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lander Egaña-Gorroño. The network helps show where Lander Egaña-Gorroño may publish in the future.
Co-authors
The 25 scholars most cited alongside Lander Egaña-Gorroño, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 161 | |
| 2 | 2021 | 59 | |
| 3 | 2020 | 49 | |
| 4 | 2014 | 47 | |
| 5 | 2012 | 29 | |
| 6 | 2019 | 25 | |
| 7 | 2016 | 20 | |
| 8 | 2017 | 17 | |
| 9 | 2021 | 15 | |
| 10 | 2021 | 15 | |
| 11 | 2018 | 14 | |
| 12 | 2020 | 10 | |
| 13 | 2014 | 9 | |
| 14 | 2021 | 7 | |
| 15 | 2016 | 7 | |
| 16 | 2014 | 3 | |
| 17 | 2012 | 2 |
About Lander Egaña-Gorroño
Lander Egaña-Gorroño is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Emergency Medicine, Genetics and Molecular Biology, having authored 17 papers that have together received 489 indexed citations. Recurring topics across this work include HIV-related health complications and treatments (4 papers), Advanced Glycation End Products research (4 papers), Diabetes and associated disorders (3 papers), HIV Research and Treatment (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Diabetes Management and Research (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper) and Fatty Acid Research and Health (1 paper). The work is most often cited by research in Clinical Biochemistry (147 citations), Virology (50 citations), Emergency Medicine (45 citations), Endocrinology, Diabetes and Metabolism (75 citations) and Cancer Research (56 citations). Lander Egaña-Gorroño has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Ann Marie Schmidt, Alexander Shekhtman, Ravichandran Ramasamy, Raquel López‐Díez, Sergey Reverdatto, Paul F. Gugger, Gautham Yepuri, Mireia Arnedo, Tuixent Escribà and Felipe García. Their work appears in journals such as PLoS ONE, Journal of Lipid Research, AIDS, Frontiers in Cardiovascular Medicine and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.